GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » Cyclically Adjusted Revenue per Share

Diasorin SpA (CHIX:DIAM) Cyclically Adjusted Revenue per Share : €18.75 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Diasorin SpA's adjusted revenue per share for the three months ended in Mar. 2025 was €5.808. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €18.75 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Diasorin SpA's average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 13.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Diasorin SpA was 16.60% per year. The lowest was 6.90% per year. And the median was 13.60% per year.

As of today (2025-06-20), Diasorin SpA's current stock price is €93.00. Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €18.75. Diasorin SpA's Cyclically Adjusted PS Ratio of today is 4.96.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Diasorin SpA was 20.24. The lowest was 4.80. And the median was 9.16.


Diasorin SpA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Diasorin SpA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Cyclically Adjusted Revenue per Share Chart

Diasorin SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.63 12.44 15.61 15.63 18.25

Diasorin SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.35 18.25 17.64 18.25 18.75

Competitive Comparison of Diasorin SpA's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted PS Ratio falls into.


;
;

Diasorin SpA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diasorin SpA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=5.808/122.5000*122.5000
=5.808

Current CPI (Mar. 2025) = 122.5000.

Diasorin SpA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.323 100.279 2.838
201509 2.236 100.000 2.739
201512 2.380 99.814 2.921
201603 2.265 99.600 2.786
201606 2.589 99.900 3.175
201609 2.685 100.100 3.286
201612 2.849 100.300 3.480
201703 2.876 101.000 3.488
201706 2.954 101.100 3.579
201709 2.728 101.200 3.302
201712 3.049 101.200 3.691
201803 2.969 101.800 3.573
201806 3.047 102.400 3.645
201809 2.976 102.600 3.553
201812 3.205 102.300 3.838
201903 3.125 102.800 3.724
201906 3.279 103.100 3.896
201909 3.194 102.900 3.802
201912 3.307 102.800 3.941
202003 3.187 102.900 3.794
202006 3.792 102.900 4.514
202009 4.161 102.300 4.983
202012 4.952 102.600 5.912
202103 4.870 103.700 5.753
202106 4.543 104.200 5.341
202109 6.270 104.900 7.322
202112 6.918 106.600 7.950
202203 6.536 110.400 7.252
202206 6.048 112.500 6.586
202209 6.074 114.200 6.515
202212 6.525 119.000 6.717
202303 5.419 118.800 5.588
202306 5.382 119.700 5.508
202309 5.067 120.300 5.160
202312 5.664 119.700 5.796
202403 5.416 120.200 5.520
202406 5.631 120.700 5.715
202409 5.383 121.200 5.441
202412 5.538 121.200 5.597
202503 5.808 122.500 5.808

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Diasorin SpA  (CHIX:DIAm) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Diasorin SpA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=93.00/18.75
=4.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Diasorin SpA was 20.24. The lowest was 4.80. And the median was 9.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Diasorin SpA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Industry
Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines